Ideas For Now-

Alright the one thing i don't like about the Evelo upgrade is it comes after a a down $1 8% day yesterday which could of prompted this save upgrade.... If it was down for no no good reason i would have done the same thing...

Evelo Bio rises 15% on positive EDP1815 data in atopic dermatitis
Dec. 09, 2020 8:00 AM ETEvelo Biosciences, Inc. (EVLO)
  • Evelo Biosciences(NASDAQ:EVLO) jumps 15% premarket on positivetopline datafrom its Phase 1b clinical trial of EDP1815 in 23 evaluable subjects with mild to moderate atopic dermatitis.
  • The primary endpoint was safety and tolerability. EDP1815 was well tolerated with no serious adverse events.
  • Clinical differences between EDP1815 and placebo were statistically significant at day 56 in both the percentage change in EASI (62% difference, p=0.034) and in IGA*BSA (71% difference, p=0.019).
  • Improvements in these measures were observed as early as day 14.
  • At day 56, 10/16 patients in the active group showed improvements in EASI score, compared to 0/7 of patients in the placebo group.
  • These results provide further evidence that modulating SINTAX can drive significant clinical benefit without the need for systemic exposure.
  • The company looks forward to sharing the complete dataset from this Phase 1b trial in early 2021 and advancing EDP1815 into later-stage trials.
 
Wow I just looked and at the date of that PR Dec 9-- the stk was $6!!!! Oh baby how did I miss this! It's up 100% in a month... This is lightning fire... ooopha.... Were they to miss their numbers this would crash so hard.... This is not like me... Dec 9th must of been Christmas shopping.... where was I!?
 
From the minds that brought us aqua bounty & Salmon comes another fish based idea-- who likes shrimp?

NaturalShrimp: The Next Generation Of Shrimp Aquaculture
Dec. 29, 2020 3:22 PM ETNaturalShrimp Incorporated (SHMP)
  • NaturalShrimp has solved a 50 year problem in the aquaculture industry with their patented process that grows fresh, healthy, environmentally sustainable seafood without the use of antibiotics or chemicals.
  • NaturalShrimp has applied for listing on the NASDAQ which will be a tipping point allowing institutional investors and capital to flow into their growing business.
  • Shrimp is the significantly highest consumed seafood in the United States.
  • Massive scalability potential in the growing domestic shrimp market that currently sees only 5% of shrimp consumption coming from United States producers.
  • In the words of CEO Gerald Easterling, SHMP will "rise from the ashes".
Background

NaturalShrimp(OTCQB:SHMP)was founded in 2001 and is headquartered in Dallas, Texas. They currently have production facilities outside San Antonio, Texas. They are an aquaculture technology company (Aquatic farming). They utilize a land based recirculating aquaculture system (RAS) using negative oxygen reduction potential (ORP) and anti-oxidation treatments (Gas and Plasma) in the production of fresh shrimp and seafood.??????? More gas plasma please! lol...

Sushi grad sweet and buttery srimp!!! Yummmmmm!
 
You love messing with me... a PM " Personal Message I assume so I went to Inbox and the last time you sent me something was the 12th of Dec. Alerts are even older several from 2013.
Sent ya a pm... Prime Message ????

Like Star Trek - A prime Directive... all you must do is find it within the complex computer system of Elite Trader....
 
I came up with a theory Van and I want to test it. The theory is Robin Hood is scraping this thread an with an algo... that's the rumor.. not reading it word for word a computer is scraping us apparently so I figured out the algo in question likes it when I combine the Word Apple with XPeng or XPEV. So allow me this brief message:

VAN (also in Algo)

VAN YOU WERE RIGHT! XPENG AND APPLE LIKE EACH OTHER ALOT. XPEV AND AAPL HAVE HIGH DESIGN MERITS. THAT'S APPLE COMPUTER- THEY COULD BE LOOKING TO MAKE AN ELECTRIC CAR WITH X PENG. WHY NOT?- XPEV

WATCH---
 
MEOH- This came across our screen the other day and again today-

--Methanex price target raised to $60 from $50 at BMO Capital (MEOH) BMO Capital analyst Joel Jackson raised the firm's price target on Methanex to $60 from $50 and keeps an Outperform rating on the shares. The analyst notes that the January and Q1 methanol price benchmarks are trending much better than expected, with North America price rising $83 per ton this week vs. the $55-$60 per ton spot price increases this month, matching the "largest month-over-month gain in 10 years. Jackson adds that he is now modeling Methanex FY21 EBITDA at $1.05B vs. $696M prior forecast, matching the company's 2018 levels.

Methanex Corporation (MEOH)

$47.22+1.48 (+3.24%)<------

Of the last 2 days I think this maybe the best idea...
 
You must log in or register to reply here.
Back
Top